Market Tracker

05/25 5:15pm ET

Zoetis Inc (NYSE:ZTS)

83.67
Delayed Data
As of May 25
 -1.08 / -1.27%
Today’s Change
59.50
Today|||52-Week Range
86.38
+16.14%
Year-to-Date
Pharma Stock Roundup: Zoetis to Buy Abaxis, NVS Gets FDA Nod for Migraine Drug
May 18 / Zacks.com - Paid Partner Content
Abaxis (ABAX) to be Acquired by Zoetis, Shares All-Time High
May 17 / Zacks.com - Paid Partner Content
Company News For May 17, 2018
May 17 / Zacks.com - Paid Partner Content
Zoetis (ZTS) Inks Deal to Acquire Abaxis for $2 Billion
May 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close84.75
Today’s open84.87
Day’s range83.55 - 85.05
Volume1,964,008
Average volume (3 months)2,711,943
Market cap$40.7B
Data as of 4:00pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)+6.06%
Earnings growth (this year)+27.61%
Earnings growth (next 5 years)+14.00%
Revenue growth (last year)+8.57%
P/E ratio42.0
Price/Sales6.69
Price/Book23.09

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...+0.60+0.51%
BAXBaxter International...+0.12+0.17%
INCYIncyte Corp+1.76+2.64%
VRTXVertex Pharmaceutica...+0.53+0.34%
Data as of 4:00pm ET, 05/25/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)$0.71
Annual revenue (last year)$5.3B
Annual profit (last year)$864.0M
Net profit margin16.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Juan Ramón Alaix
Executive Vice President &
President-US Operations
Kristin C. Peck
Corporate headquarters
New Jersey, New Jersey

Forecasts